Zymeworks, Inc. (ZYME)
23.62
+0.74
(+3.23%)
USD |
NASDAQ |
Mar 16, 16:00
23.28
-0.34
(-1.44%)
After-Hours: 04:13
Zymeworks Total Assets (Quarterly) : 346.53M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Royalty Pharma Plc | 19.62B |
| Krystal Biotech, Inc. | 1.334B |
| Scholar Rock Holding Corp. | 404.27M |
| Xeris Biopharma Holdings, Inc. | 392.94M |
| Stoke Therapeutics, Inc. | 360.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 78.03M |
| Shareholders Equity (Quarterly) | 268.50M |
| Debt to Equity Ratio | 0.068 |
| Current Ratio | 5.878 |
| Net Debt Paydown Yield | 0.02% |